Study Investigates Bee Venom as an Adjunct to Parkinson's Disease Therapy
Researchers are investigating the potential of bee venom as an adjunct therapy to traditional L-DOPA/carbidopa treatments for Parkinson's disease. The study aims to determine if the venom can provide neuroprotective benefits when used alongside conventional medication.
Why it matters
Finding effective adjunct therapies for neurodegenerative diseases could significantly improve the quality of life for Parkinson's patients.
There were 1,923 press releases posted in the last 24 hours and 481,197 in the last 365 days.
Exploring bee venom as a potential adjunct to L-DOPA/carbidopa treatment for Parkinson’s disease.
Scientists investigate bee venom as a potential companion to conventional Parkinson’s therapy
Ningning Wang Neuroprotection email us here 1051322541 ext.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in